Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education to Reduce Emergency Department Visits, Re-admissions and Adverse Cardiovascular Outcomes in Hypertensive Disorder of Pregnancy
Ochsner Health System
296 participants
Mar 17, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are: Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes? Participants will: View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum
Eligibility
Inclusion Criteria6
- Age of at least 18 years.
- Postpartum status.
- Experience new-onset hypertension during pregnancy.
- Enrollment in Connected MOM.
- Ability to provide informed consent.
- Establish medical care within the Ochsner System to facilitate data collection.
Exclusion Criteria10
- History of preeclampsia or gestational hypertension during previous pregnancy
- History of chronic hypertension
- History of coronary artery disease (myocardial infarction, coronary stent placement, coronary artery bypass grafting, spontaneous coronary artery dissection)
- History of ischemic CVA
- History of Congestive heart failure
- Renal dysfunction
- Liver dysfunction
- Left ventricular dysfunction
- Congenital heart disease
- Still birth at delivery
Interventions
Those in the intervention arm will watch a short educational video.
Those in the intervention group will receive regular text message reminders to check their blood pressures
Those in the intervention group will have a lower blood pressure threshold to titrate their BP medications towards
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06920563